Bradley Heiges, MD
Orthopaedic Surgery of the Spine · Savannah, GANPI 1871565481
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $220,155 of the $233,210 with a category attached, or 94.4%. Globus Medical accounts for 94.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $73,071 and has fallen 99.5% since, to $383 in 2025.
Across 129 payments — averaging $1807.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$220K
- Alphatec Spine, Inc$5K
- Curiteva, Inc.$3K
- Boston Scientific$2K
- Relievant Medsystems, Inc.$1K
- Arthrex$601
- plus $660 from 7 others
What the payments were for
- Royalty or licence$220,15594%
- Travel & lodging$9,2624%
- Food & beverage$3,7932%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical(2 entities) | 33 | $220,223 |
| Alphatec Spine, Inc | 8 | $4,964 |
| Curiteva, Inc. | 2 | $3,182 |
| Boston Scientific | 61 | $2,136 |
| Relievant Medsystems, Inc. | 8 | $1,444 |
| Arthrex | 9 | $601 |
| Team 1, LLC | 1 | $538 |
| Abbott | 2 | $38 |
| Medtronic | 1 | $27 |
| KCI USA, Inc. | 1 | $19 |
| Lemaitre Vascular, Inc. | 1 | $16 |
| Eagle Pharmaceuticals, Inc. | 1 | $15 |
| Forte Bio-pharma LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CoRoent$220,002
- PLIF$185,942
- MaXcess$175,579
- SpheRx$168,690
- Other - Miscellaneous$4,552
- Intracept$1,170
- WaveWriter Alpha Prime 16$523
- SPECTRA WAVEWRITER$205
- KODIAK$132
How this compares
$233,210 in reported general payments places this provider in the 80th percentile of 57 orthopaedic surgery of the spine providers in Georgia.
See all orthopaedic surgery of the spine providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 151 | $2,070 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 95 | $858 |
| Methocarbamol | 38 | $544 |
| Celecoxib | 42 | $517 |
| Pregabalin | 20 | $434 |
| Tizanidine Hcl | 70 | $307 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $298 |
| Cyclobenzaprine Hcl | 62 | $258 |
| Tramadol Hcl | 59 | $191 |
| Meloxicam | 67 | $175 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 12 | $103 |
| Methylprednisolone | 13 | $99 |
| Cephalexin | 15 | $80 |
| Prednisone | 23 | $53 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Savannah
- Raphael RoybalSavannah$400K
- Edward FakhreSavannah$8K
- John HellerAtlanta$4.2M
- Scott BodenAtlanta$1.5M
- Justin BundyAugusta$1.4M
- John RheeAtlanta$1.1M
- Tapan DaftariAustell$759K
- Brad PrybisStockbridge$659K
- Paul JeffordsAtlanta$651K
- Hewatt SimsDouglas$376K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.